JONATHAN ROTHSCHILD DIR, BO
$39,900 5,400 shares from 8/27/15 to 8/28/15 at prices from $7.17 to $7.23
Google insider insights and search on ICCC if interested to look up.
Just adding that the stock has picked up some short interest dynamic this year, around the co. earnings reports.
Take out the MAST OUT development expenses and earnings would have been around 12 cents. Makings of a cheap P/E for a company growing sales at 40% (first 6-months of 2015 vs first 6-months 2014) and a $1.45M backlog. Remember the Scours market has only a 10% penetration by ICCC or its competitors. Lots of room for all to grow but ICCC has been taking 65% of the new market penetration.
Sentiment: Strong Buy
I missed that milestone/note regarding the USDA and rotavirus. I wanted to add too, the need to watch the yoy exponential growth (reflected in the yoy earnings comparison). As you said, this is the stuff that gets heavyweight attention.
agree that mastout in the longer term has greater revenue and earnings potential but the new rotovirus indication WILL take market share from this niche market. I believe it was estimated at 35 mil. annually in US. ICCC traditionally had about 25% share. 2015 is likely to see this go to 1/3. with new indication and one competitor Knocked Out look for near 50%.
as percent change from (10) to 3 cents is worth noting. additionally, this reported
quarter (q2) and the present quarter (q3) are the weakest. The new indication for first defense and mastout potential allows plenty for higher valuations. see you there
From the company's investor presentation:
First year MAST OUT sales estimated to be $5.4M and growing to 31.7M by year 10
Sentiment: Strong Buy
This stock is about Mast Out--in the meantime, they're profitable and paying for their R&D and growing their business by means of their other products.
It means too, they''re growing future sales opportunities for Mast Out on their own. It's been their plan.
A couple points I thought were interesting were:
In order to benefit from additional pilot work being conducted in the Company's small-scale Nisin plant (which will improve the quality of the regulatory submission addressing the manufacturing objectives for Mast Out®), the first submission of this Technical Section is now expected during the first half of 2016; and
Work on facility modifications and new equipment installations to increase production capacity to meet growing sales demand is underway and on schedule.
Dey got planz.